A source told Bloomberg that Lone Star Funds closed its third real estate fund with investor commitments reaching USD 6.6 billion.
North America
Brixmor set to raise USD 905.6 million in IPO
Brixmor Property Group would be raising up to USD 905.6 million when it goes public, helping make 2013 the biggest year for IPOs in the US real estate market.
Consol Energy agrees on asset sale to Murray Energy Corp
Consol Energy would be selling some of its assets to Murray Energy Corp in a deal worth USD 850 million.
Startup IfOnly scores USD 12 million from investors
IfOnly was able to raise USD 12 million from investors in a round led by New Enterprise Associates. San Francisco-based startup IfOnly gathered USD 12 million in capital commitments from various investors.
KKR buys minority stakes in rural mobile companies
Private equity company KKR purchased minority stakes in rural wireless infrastructure-focused companies run by Associated Partners.
Latest News
CVSL Inc offered to buy Blyth Inc for USD 268 million, according to sources interviewed by Bloomberg.
A stockholder of NQ Mobile Inc filed a case against the Chinese firm for incurring losses after a research report said NQ had inflated its revenues.
General Growth Properties bought a 50% stake in urban stores in San Francisco for USD 82 million. General Growth Properties Inc purchased stakes in two buildings in San Francisco.
Shane Victorino would not be starting for the Boston Red Sox on Game 5 of the Major League Baseball World Series 2013.
A report from the Associated Press revealed that more US troops were taking refuge in military lipo to meet strict physical fitness requirements.
The consolidation of Anheuser-Busch InBev and SABMiller was a natural progression when there were only a few markets to tap, said industry analysts.
Google Inc had not been shy investing large amounts of capital in data centers to improve its Internet infrastructure.
Apple Inc's iPhone 5C had yet to challenge the dominance of Samsung Electronics and other companies using Google Inc's Android software in the cheaper smartphone market.
Analysts said the European Commission's approval of Actelion's lung disease drug would have potential investors bid for the Switzerland-based drugmaker.
